{
  "drug_name": "Meropenem-vaborbactam",
  "url": "https://wikem.org/wiki/Meropenem-vaborbactam",
  "scraped_at": "2026-01-10T07:57:14.061521",
  "sections": {
    "Administration": {
      "text": "Type:\nCarbapenem\n+beta lactamase inhibitor\nDosage Forms: 2 gram (1 gram each) solution reconstituted\nRoutes of Administration: IV\nCommon Trade Names: Vabomere",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Carbapenem",
          "url": "https://wikem.org/wiki/Carbapenem"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "Complicated UTI (including pyelonephritis)\n4 g IV q8h (administered over 3 hours)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "",
      "subsections": {
        "Pregnancy_Rating": {
          "text": "Unknown",
          "tables": []
        },
        "Lactation_risk": {
          "text": "Meropenem is present in breast milk",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "eGFR >50: none\neGFR 30 to 49: 2 g q8h\neGFR 15 to 29: 2 g q12h\neGFR <15: 1 g q12h\nESRD on HD: Administer after HD on dialysis days",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "None",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pregnancy_Rating": {
      "text": "Unknown",
      "subsections": {
        "Lactation_risk": {
          "text": "Meropenem is present in breast milk",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "eGFR >50: none\neGFR 30 to 49: 2 g q8h\neGFR 15 to 29: 2 g q12h\neGFR <15: 1 g q12h\nESRD on HD: Administer after HD on dialysis days",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "None",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Lactation_risk": {
      "text": "Meropenem is present in breast milk",
      "subsections": {
        "Renal_Dosing": {
          "text": "eGFR >50: none\neGFR 30 to 49: 2 g q8h\neGFR 15 to 29: 2 g q12h\neGFR <15: 1 g q12h\nESRD on HD: Administer after HD on dialysis days",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "None",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Renal_Dosing": {
      "text": "eGFR >50: none\neGFR 30 to 49: 2 g q8h\neGFR 15 to 29: 2 g q12h\neGFR <15: 1 g q12h\nESRD on HD: Administer after HD on dialysis days",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "None",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "None",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "DVT (<1%)\nIncreased risk of seizures",
          "tables": []
        },
        "Common": {
          "text": "Phlebitis\nHeadache\nHypokalemia\nDiarrhea\nIncreased ALT/AST\nInfusion site reaction",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "DVT (<1%)\nIncreased risk of seizures",
      "subsections": {
        "Common": {
          "text": "Phlebitis\nHeadache\nHypokalemia\nDiarrhea\nIncreased ALT/AST\nInfusion site reaction",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Phlebitis\nHeadache\nHypokalemia\nDiarrhea\nIncreased ALT/AST\nInfusion site reaction",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: Meropenem 1.2 hours; Vaborbactam 1.68 hours\nMetabolism:\nExcretion: Meropenem (urine); Vaborbactam (urine)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Meropenem\ninhibits bacterial cell wall synthesis\nVaborbactam is a beta-lactamase inhibitor that protects meropenem from degradation by KPC",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Meropenem",
          "url": "https://wikem.org/wiki/Meropenem"
        }
      ]
    },
    "Comments": {
      "text": "Cost: 1 g: ~$200",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}